Home » Stocks » SurModics

SurModics, Inc. (SRDX)

Stock Price: $40.92 USD 0.06 (0.15%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 558.36M
Revenue (ttm) 103.14M
Net Income (ttm) 7.62M
Shares Out 13.65M
EPS (ttm) 0.56
PE Ratio 73.07
Forward PE 666.67
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $40.92
Previous Close $40.86
Change ($) 0.06
Change (%) 0.15%
Day's Open 41.23
Day's Range 40.39 - 41.20
Day's Volume 13,752
52-Week Range 22.06 - 49.00

More Stats

Market Cap 558.36M
Enterprise Value 497.80M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 13.65M
Float 13.14M
EPS (basic) 0.57
EPS (diluted) 0.56
FCF / Share 1.52
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.37%
FCF Yield 3.71%
Payout Ratio n/a
Shares Short 364,740
Short Ratio 7.41
Short % of Float 2.78%
Beta 0.98
PE Ratio 73.07
Forward PE 666.67
P/FCF Ratio 26.94
PS Ratio 5.41
PB Ratio 4.28
Revenue 103.14M
Operating Income 4.62M
Net Income 7.62M
Free Cash Flow 20.73M
Net Cash 60.56M
Net Cash / Share 4.44
Gross Margin 32.78%
Operating Margin 4.48%
Profit Margin 7.40%
FCF Margin 20.10%
ROA 2.31%
ROE 6.12%
ROIC 6.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$64.25*
(57.01% upside)
Low
57.0
Current: $40.92
High
76.0
Target: 64.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue10081.3473.1171.3761.9057.4456.1351.9352.7654.49
Revenue Growth23.04%11.25%2.45%15.3%7.76%2.33%8.1%-1.57%-3.18%-
Gross Profit86.4467.3461.6960.4653.2849.4248.2344.5146.0147.68
Operating Income6.47-8.807.1016.8619.0918.5818.8216.3415.5211.99
Net Income7.59-4.463.939.9911.9512.0315.1710.23-18.51-21.09
Shares Outstanding13.3913.1613.1513.0013.0313.6314.4617.3217.4217.37
Earnings Per Share0.55-0.340.290.760.900.871.030.59-1.06-1.21
EPS Growth---61.84%-15.56%3.45%-15.53%74.58%---
Operating Cash Flow8.0434.0514.0525.1715.0218.1817.6716.1119.9622.01
Capital Expenditures-5.99-9.09-6.43-8.10-1.84-2.28-1.84-0.76-1.55-2.78
Free Cash Flow2.0524.967.6217.0613.1915.9115.8215.3518.4019.23
Cash & Equivalents55.2965.0248.3446.9455.5946.5525.7129.6638.4420.50
Net Cash / Debt55.2965.0248.3446.9455.5946.5525.7129.6638.4420.50
Assets16016413713398.71105102104157170
Liabilities37.3555.5325.0426.066.846.148.119.3317.1715.92
Book Value12310911210791.8798.7593.8294.99140154
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name SurModics, Inc.
Country United States
Employees 369
CEO Gary R. Maharaj

Stock Information

Ticker Symbol SRDX
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: SRDX
IPO Date March 4, 1998

Description

Surmodics, together with its subsidiaries, provides medical devices and in vitro diagnostic technologies to the healthcare industry in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment designs, develops, and manufactures interventional medical devices primarily for the peripheral vascular market; and offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, urology, and other markets. The Vitro Diagnostics segment provides stabilization products, substrates, antigens, and surface coatings to diagnostics customers; and manufactures or sells components for in vitro diagnostic immunoassay and molecular tests, as well as surface coatings to the diagnostic, biomedical research, and life science markets. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.